Researchers track side effects of Blood-Clotting drug in haemophilia patients
NCT ID NCT04682145
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study gathers safety information from a European registry about the drug turoctocog alfa pegol, used to treat haemophilia A. Researchers will count and analyze side effects reported by patients already in the registry. No extra visits or tests are required from participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Søborg, 2860, Denmark
Conditions
Explore the condition pages connected to this study.